USMEDSA Urology Coordinating Team 2000 Accomplishments vs Objectives OBJECTIVES ACCOMPLISHMENTS Coordinate Merck Activities & Exhibits at Medical Meetings • Very successful exhibit presence at AUA 2000 Annual Meeting, Pri-Med, AACE & AAFP meetings • Sponsored BPH Week as part of AFUD’s 2nd Annual Prostate DUCATE PHYSICIANS
Health Month • AUA Annual meeting: hosted Merck Advocate Event (450 Uro’s), sponsored- AUA CME BPH Symposia (650 Uro’s), AUA Education Store, AUA CD ROM of Course Handouts (6000 MD’s), AUA Website, Abstracts Online, & Annual Meeting Planner • Provided the Audience Response System for the AUA Board Review Courses • Supported the: AUA Long Range Strategic Planning, AUA Chiefs of Urol Program, AUA/EAU Exchange Program ABOUT DATA FOR PROSCAR Provide Medical & Scientific Information • Conducted 3 Regional CME Programs, “Advances in the Eval. & Pharmacologic 3)3
Tx of BPH”. Monograph published & will be posted on Medscape for CME credit for 1 yr • Developed AND ASSIST IN THE LAUNCH OF
exhibits for AUA 2000 Annual Meeting (& sponsored CD ROM), Pri-Med Meetings, AACE & AAFP meetings. • Sponsored AUA CME program that is being evaluated by Audio Digest for inclusion in its tape program. • Worked with Annenberg Center for Health Sciences to create a Journal Plus Program (CME) on “The Role of Serum PSA in BPH” • Database updated with all product AUA abstracts, HCP’s product & disease questions answered in writing &/or by personal calls. • *Ongoing participation in MRL manuscript review/revision process, & Medical School Grant Committee • *Prostatitis & Hematuria MSGP’s- Assisted US investigators with investigator-IND application, provided investigators with double-blind THE PSA LABEL CHANGES
medication via outside vendor • * Participated in WPCRC activities related to the cir
cular additions on the relationships of PSA to prostate volume, PSA to outcomes, & prostate volume to outcomes. • * Collected & analyzed competitive product
information at AUA (alpha blockers, Dutasteride, herbal products)
Training of Urology Sales Force • High quality training lectures given to sales force trainees—top rating given by sales trainees • Trained sales force on key promotional piece “A Profile of Proscar” • Pro-actively wrote three SUPPORT MARKETING AND
Medical Background texts & tests for PSA launch • Reviewed/edited & assisted in writing sales bulletins (e.g., PREDICT study, Dr. Pitt’s negative editorial in J Urol) Medical Review & Assistance in Development of Promotional Materials • Participation in M/L boards • Researched & provided medical literature to support promotional efforts • Assistance to TBG & legal in drafting SALES TEAMS WITH
promotional materials by providing product, medical & urological expertise (e.g., “A Profile of Proscar”, “BPH: A Primary Care Perspective”, review of all key studies ‘92-’00) • * M/L board liaison with MRL MEDICAL & SCIENTIFIC Issue Research & Analysis Responded to 1
00% of Issues • Ongoing monitoring of the finasteride & competitive disease literature & the Internet, for US MEDSA, TBG, WHHM & MRL (e.g., quarterly alfusozin searches for
MEDSA & TBG; identification of AUA abstr
acts of interest for the Merck AUA meeting book) • *Ongoing extensive literature & database research & analysis (e.g., intraprostatic DHT levels; Lower Urinary Tract Symptoms) INFORMATION • *Participation in USHH-MRL-WHHM Prostate Cancer Product Development Team Work With Marketing to Develop & Execute a Plan to Train Sales Force • Developed MEDSA Dutasteride plan • *Created outline, provided source materials and reviewed WHHM MB (outline and source material being incorporated into promotional slide set) • Assisted TBG in planning & implementing promotional strategy to pre-empt Glaxo • *Created & gave training lectures to both HSA’s & to USHH team Issue Research and Analysis • Performed 100% of liter
ature searches & analyses • *Acti H
ve participants in the USHH team & USHH/WHHM/MRL Counterstrategy Task Force to plan & implement strategy • *Assisted TBG in analyzing
competitive data, planning & implementing counter- & promotional-strategy to pre-empt Glaxo
DUTASTERIDE Search and Monitor Product and Competitive Literature • Quarterly Literature Search on Dutasteride • Performed quarterly surveillance literature searches for the task force (TBG, MRL, WHHM) Search and Monitor Literatur PREPARE FOR THE M3 ANTAGONIST† e, Databases, and Internet • Begin to Develop Center of Expertise in Neurourology • Provided literature for new product marketing, market research, etc. • Collected voiding dysfunction
& incontinence related material at AUA •
Identified texts for library • Assisted in early strategic planning – PENDING PHASE IIB TRIAL RESULTS †Did not continue into Phase III Henry Rodrique, APA; Joanne Palmisano, Lee Halper, CDP; Leonard Silverstein (chair), Kathleen Peeples-Lamirande, Medical Services; Tom Abbott, ORM; Fran Kaiser, RMD
Designed and Produced by the DTP Group/InfoManagement Team/Medical Services
1 The intercellular junction where ionic channels pierce the adjacent membrane is called: (1) desmosome nexus tight junction synapse lateral interdigitations 2 The disk-shaped intercellular junction where a dense plaque with filaments is present on the cytoplasmic surface of each opposing plasma membrane is called: (1) desmosome nexus tight junction synapse lateral interdigitations 3 Cytoplasm bas